Eli Lilly: The Most Expensive Stock in Pharma; and Maybe the Best

AI Briefing

• – Eli Lilly's stock has been the most expensive in the pharmaceutical sector, with a market capitalization of over $250 billion. Pfizer Inc. and Novo Nordisk A/S also make the list, with market capitalizations of over $200 billion and $120 billion, respectively. The three companies are among the largest players in the industry, with Eli Lilly being a leading manufacturer of human and animal health medications.